Abstract：Objective To analyze the mortality rate of chronic obstructive pulmonary disease (COPD) and its trend in residents in Wuhan from 2009 to 2018. Methods COPD mortality data from 2009 to 2018 were from Wuhan population based mortality surveillance system. The crude and standardized mortality rates of COPD were calculated of different geographic distribution, different gender and different age, and the trend over years were analyzed. The software SAS 9.4 was used for linear regression analysis, and the annual percent change (APC) was calculated. Results The crude mortality rate and the standardized mortality rate of COPD were 33.01/100 000 and 23.03/100 000 respectively in residents in Wuhan from 2009 to 2018. The crude mortality rate showed an increasing trend from 2009 to 2018 and the APC was 4.08%, (P＜0.05). The crude mortality rate was 41.23/100 000 in males and 24.47/100 000 in females（χ2＝6.37, P＜0.05). The crude mortality rate was 35.29/100000 in rural areas and 32.28/100 000 in urban areas, and there was no statistical significance(χ2＝0.20, P＞0.05). The crude mortality rate showed increasing trends in males and rural areas, and the APC were 4.08% (P<0.05) and 5.10% (P<0.05) respectively. There was no statistical significance in the trends of females and urban areas, and the APC was 2.02% (P>0.05). Except for those aged 35-45 years old, the standardized mortality rate of COPD in all age groups showed a downward trend from 2009 to 2018. Conclusion The COPD mortality in residents in Wuhan increased from 2009 to 2018. More attention should be paid to reducing COPD mortality in rural residents, males and elderly population.
赵原原，杨念念，代娟，金琦曼，张晓霞，严亚琼. 武汉市2009—2018年慢性阻塞性肺疾病死亡率变化趋势分析[J]. 中国医院统计, 2021, 28(2): 101-104.
Zhao Yuanyuan, Yang Niannian, Dai Juan, Jin Qiman, Zhang Xiaoxia, Yan Yaqiong. Analysis on the trend of COPD mortality of the residents in Wuhan during 2008-2019. journal1, 2021, 28(2): 101-104.
［1］陈亚红.2020年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读［J］.中国医学前沿杂志(电子版),2019,11(12):32-50.
［2］WANG C, XU J Y, YANG L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health［CPH］study): a national cross sectional study ［J］. Lancet, 2018, 391（10131）：1706-1717.
［3］殷鹏，王黎君，刘世炜，等．1990年与2010年中国15岁以上人群慢性阻塞性肺疾病的疾病负担分析［J］．中华预防医学杂志，2015，49(4)：334-338．
［4］2017年中国死因监测数据集［DS］.北京：中国科学技术出版社，2018:64-247.
［5］李晓燕，胡楠，黄正京，等．2004—2005年中国居民呼吸系统疾病死亡水平及构成［J］．中华预防医学杂志，2010，44(4)：298-302．
［6］张艳, 刘庆敏, 付文,等. 2006—2018年浙江省杭州市居民慢性阻塞性肺疾病死亡率变化趋势分析［J］.疾病监测，2020,35(5):446-450.
［7］周林, 刘月玲, 张军,等. 2011—2014年济南市慢性阻塞性肺疾病死亡特征和疾病负担分析［J］.中国卫生统计,2016,33(2):280-281.
［8］罗文婷,林艺兰.厦门市慢性阻塞性肺疾病死亡趋势分析及预测［J］.疾病监测与控制,2016,10(10):783-785.
［9］武汉市统计局.武汉统计年鉴［M］.北京.中国统计出版社，2018.
［10］王德征，张辉，徐忠良，等．天津市2000—2016年慢性阻塞性肺疾病死亡率变化趋势分析［J］．中华预防医学杂志，2018，52(7)：709-714．
［11］伍春燕,邓志宏.2015年武汉市15岁及以上居民烟草流行现状调查［J］.现代预防医学,2018(6):980-984.
［12］WANG S B, UNGVARI G S, FORESTER B P, et al. Gender differences in general mental health, smoking, drinking and chronic diseases in older adults in Jilin Province, China［J］. Psychiatry Res, 2017, 251:58-62.
［13］程意,唐明,李刚,等.上海市郊县居民 COPD 相关疾病死亡率变化趋势分析［J］.临床肺科杂志，2014，19（4）：659-663.
［14］FANG L W, GAO P, BAO H L, et al. Chronic obstructive pulmonary disease in China: A nationwide prevalence study［J］. Lancet Respir Med, 2018, 6(6):421-430.
［15］张阳,王宁,樊静,等.2014—2015年中国40岁及以上慢性阻塞性肺疾病患者药物治疗率及其影响因素分析［J］.中华流行病学杂志,2020,41(5):678-684.
［16］吕学莉,丛舒,樊静,等.2014—2015年中国40岁及以上慢性阻塞性肺疾病患者肺功能检查率及其影响因素分析［J］.中华流行病学杂志,2020,41(5):672-677.
［17］温莹，何柳，翟屹，等．流行性感冒病毒裂解疫苗和23价肺炎球菌多糖疫苗改善老年人慢性阻塞性肺疾病的社区干预试验［J］．中华流行病学杂志，2018，39(6)：792-798．
［18］苏晓珏,范槐芳,王丽.COPD老年患者康复护理措施对其肺功能及预后的影响分析［J］.中国医院统计,2017,24(3): 212-214.
［19］李俊林,黄远霞,梅欣,等.2015年湖北省武汉城市与农村成人吸烟现状比较与分析［J］.中国健康教育,2018,34(7):594-597.
